FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2027157040> ?p ?o ?g. }

• W2027157040 endingPage "8" @default.
• W2027157040 startingPage "3" @default.
• W2027157040 abstract ": Underpinned by increased confidence in cure of metastatic seminoma by chemotherapy during the past 12 years, three management strategies for Stage I seminoma have been evaluated by six collaborating centers within the Anglian Germ Cell Tumor Group. This paper evaluates the efficacy of surveillance, prophylactic radiotherapy and adjuvant chemotherapy, and discusses these differing management approaches. : Patients were recruited into the study between 1982 and 1992. There was no randomization between treatment groups. Seventy-nine patients received prophylactic radiotherapy (median follow-up = 51 months), 67 patients had surveillance alone (median follow-up = 61 months) and 78 patients were treated with adjuvant single agent platinum (median follow-up = 44 months). Fifty-three of these patients received two courses of platinum (median follow-up = 51 months) and 25 patients received one course (median follow-up = 29 months, range 22–72 months). : There were 18 (27%) recurrences on surveillance, five (6%) after radiotherapy, one (1%) after two courses of adjuvant single agent platinum and none after one course of carboplatin. There was one death from testis cancer after radiotherapy and none after adjuvant chemotherapy treatments. Two patients died with drug resistant disease after relapse on surveillance. There was one death from a myocardial infarction after prophylactic radiotherapy and one death from suicide in the surveillance group. A retrospective quality of life questionnaire reviewing the incidence of early and late toxicity revealed no major differences though they suggest that those treated with one course adjuvant carboplatin had somewhat less sickness and an earlier return to work. : Single agent carboplatin appears well tolerated and is an effective adjuvant treatment for Stage I seminoma. A multicenter randomized trial of the different treatment modalities is required to further evaluate its use." @default.
• W2027157040 created "2016-06-24" @default.
• W2027157040 creator A5020327932 @default.
• W2027157040 creator A5025701216 @default.
• W2027157040 creator A5029795774 @default.
• W2027157040 creator A5033215155 @default.
• W2027157040 creator A5033360499 @default.
• W2027157040 creator A5041206243 @default.
• W2027157040 creator A5042145132 @default.
• W2027157040 creator A5044437404 @default.
• W2027157040 creator A5072381271 @default.
• W2027157040 creator A5077211569 @default.
• W2027157040 creator A5089547051 @default.
• W2027157040 creator A5090476810 @default.
• W2027157040 date "1994-04-01" @default.
• W2027157040 modified "2023-09-27" @default.
• W2027157040 title "Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?" @default.
• W2027157040 cites W1979369208 @default.
• W2027157040 cites W1993965140 @default.
• W2027157040 cites W2004309141 @default.
• W2027157040 cites W2012475949 @default.
• W2027157040 cites W2031454576 @default.
• W2027157040 cites W2042048473 @default.
• W2027157040 cites W2044121120 @default.
• W2027157040 cites W2047891660 @default.
• W2027157040 cites W2075226798 @default.
• W2027157040 cites W2081253330 @default.
• W2027157040 cites W2083985425 @default.
• W2027157040 cites W2093106295 @default.
• W2027157040 cites W2116996913 @default.
• W2027157040 cites W2123114747 @default.
• W2027157040 cites W2123452786 @default.
• W2027157040 cites W2136997298 @default.
• W2027157040 cites W2409718729 @default.
• W2027157040 cites W2464585541 @default.
• W2027157040 cites W2475273082 @default.
• W2027157040 cites W4300929371 @default.
• W2027157040 doi "https://doi.org/10.1016/0360-3016(94)90219-4" @default.
• W2027157040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8175442" @default.
• W2027157040 hasPublicationYear "1994" @default.
• W2027157040 type Work @default.
• W2027157040 sameAs 2027157040 @default.
• W2027157040 citedByCount "124" @default.
• W2027157040 countsByYear W20271570402012 @default.
• W2027157040 countsByYear W20271570402013 @default.
• W2027157040 countsByYear W20271570402014 @default.
• W2027157040 countsByYear W20271570402015 @default.
• W2027157040 countsByYear W20271570402016 @default.
• W2027157040 countsByYear W20271570402019 @default.
• W2027157040 countsByYear W20271570402020 @default.
• W2027157040 countsByYear W20271570402021 @default.
• W2027157040 countsByYear W20271570402022 @default.
• W2027157040 countsByYear W20271570402023 @default.
• W2027157040 crossrefType "journal-article" @default.
• W2027157040 hasAuthorship W2027157040A5020327932 @default.
• W2027157040 hasAuthorship W2027157040A5025701216 @default.
• W2027157040 hasAuthorship W2027157040A5029795774 @default.
• W2027157040 hasAuthorship W2027157040A5033215155 @default.
• W2027157040 hasAuthorship W2027157040A5033360499 @default.
• W2027157040 hasAuthorship W2027157040A5041206243 @default.
• W2027157040 hasAuthorship W2027157040A5042145132 @default.
• W2027157040 hasAuthorship W2027157040A5044437404 @default.
• W2027157040 hasAuthorship W2027157040A5072381271 @default.
• W2027157040 hasAuthorship W2027157040A5077211569 @default.
• W2027157040 hasAuthorship W2027157040A5089547051 @default.
• W2027157040 hasAuthorship W2027157040A5090476810 @default.
• W2027157040 hasConcept C126322002 @default.
• W2027157040 hasConcept C141071460 @default.
• W2027157040 hasConcept C168563851 @default.
• W2027157040 hasConcept C204243189 @default.
• W2027157040 hasConcept C2776694085 @default.
• W2027157040 hasConcept C2777863537 @default.
• W2027157040 hasConcept C2778074268 @default.
• W2027157040 hasConcept C2778239845 @default.
• W2027157040 hasConcept C2781451048 @default.
• W2027157040 hasConcept C509974204 @default.
• W2027157040 hasConcept C71924100 @default.
• W2027157040 hasConceptScore W2027157040C126322002 @default.
• W2027157040 hasConceptScore W2027157040C141071460 @default.
• W2027157040 hasConceptScore W2027157040C168563851 @default.
• W2027157040 hasConceptScore W2027157040C204243189 @default.
• W2027157040 hasConceptScore W2027157040C2776694085 @default.
• W2027157040 hasConceptScore W2027157040C2777863537 @default.
• W2027157040 hasConceptScore W2027157040C2778074268 @default.
• W2027157040 hasConceptScore W2027157040C2778239845 @default.
• W2027157040 hasConceptScore W2027157040C2781451048 @default.
• W2027157040 hasConceptScore W2027157040C509974204 @default.
• W2027157040 hasConceptScore W2027157040C71924100 @default.
• W2027157040 hasIssue "1" @default.
• W2027157040 hasLocation W20271570401 @default.
• W2027157040 hasLocation W20271570402 @default.
• W2027157040 hasOpenAccess W2027157040 @default.
• W2027157040 hasPrimaryLocation W20271570401 @default.
• W2027157040 hasRelatedWork W151172257 @default.
• W2027157040 hasRelatedWork W1984775533 @default.
• W2027157040 hasRelatedWork W1993965140 @default.
• W2027157040 hasRelatedWork W2011808318 @default.
• W2027157040 hasRelatedWork W2048005101 @default.

• next